Incruse Ellipta

"Incruse Ellipta is a dedicated maintenance treatment typically prescribed to adults living with Chronic Obstructive Pulmonary Disease, including chronic bronchitis and emphysema, to help keep airways open throughout the day. This long-acting medication is designed for regular daily use rather than sudden symptom relief, helping to improve lung function and overall quality of life for those with persistent respiratory challenges." - Rachael Clarke MRCPharm MFRPSI FRSPH (GPHC Number: 2061366)

You can buy Incruse Ellipta through our secure online pharmacy platform following a digital consultation with a registered prescriber to ensure this medication is appropriate for your respiratory needs. Once your consultation is approved, your treatment is dispensed and shipped from our pharmacy (GPHC Number: 9011560) using discreet home delivery to maintain your privacy.

The price of Incruse Ellipta at Mail my Meds reflects our commitment to providing affordable access to essential COPD maintenance treatments for patients across the UK. While the cost may vary depending on whether you are fulfilling a private or NHS prescription, we provide transparent pricing during the checkout process.

We offer various delivery methods to ensure your medication reaches you promptly and securely after your order has been clinically approved. All packages are sent in neutral, unbranded packaging to ensure the contents remain confidential while in transit to your UK address.

Incruse Ellipta is a dry powder inhaler used as a long-term maintenance therapy to manage the symptoms of Chronic Obstructive Pulmonary Disease (COPD) in adults. It belongs to a class of medicines known as bronchodilators, specifically long-acting muscarinic antagonists, which work to prevent the muscles around the lungs from tightening.

The primary active ingredient in this medication is umeclidinium bromide, which is delivered as a pre-dispensed inhalation powder. Each single inhalation provides a specific dose of umeclidinium to the lungs to maintain open airways for a full 24-hour period.

Many patients report that the Ellipta device is easy to handle due to its large dose counter and the fact it only requires a single daily application. While individual results vary, users often find that incorporating this treatment into their morning routine helps manage persistent breathlessness and chronic cough throughout their daily activities.

It is essential to read the Patient Information Leaflet (PIL) included with your medication for a comprehensive guide on use, safety and storage. You can also access digital versions of the leaflet to stay informed about the clinical specifics of umeclidinium bromide.

The active substance, umeclidinium, works by blocking muscarinic receptors in the smooth muscle of the airways, which prevents a chemical called acetylcholine from causing the muscles to contract. By relaxing these muscles, the treatment widens the air passages, making it easier for air to move in and out of the lungs for patients with damaged air sacs or blocked airways.

Using the Ellipta inhaler correctly is vital to ensure the medication reaches your lungs effectively. Follow these steps for every dose:

1. Slide the cover down until you hear a "click" to expose the mouthpiece and load the dose.
2. Breathe out fully, away from the inhaler.
3. Place the mouthpiece between your lips and close them firmly, ensuring you do not block the air vents with your fingers.
4. Take one long, steady, deep breath in through your mouth.
5. Hold your breath for about 3 to 4 seconds, or as long as comfortable, before breathing out slowly.
6. Slide the cover upwards to close the inhaler.

The standard recommended dosage for Incruse Ellipta is one single inhalation taken once daily at the same time each day. You should not exceed the prescribed dose of one inhalation in any 24-hour period, as this medication is designed to provide continuous bronchodilation throughout the day and night.

Like all medicines, this treatment can cause side effects, although not everyone will experience them. Common side effects reported by UK patients include:

• Headache
• Cough or sore throat
• Infections of the nose and throat (nasopharyngitis)
• Constipation or dry mouth
• Faster or irregular heartbeat

Before you start using this inhaler, inform your prescriber if you have a history of heart problems, narrow-angle glaucoma or an enlarged prostate. This medication contains lactose and should be used with caution if you have a severe milk protein allergy or rare hereditary problems of galactose intolerance.

Is Incruse Ellipta a steroid?

No, Incruse Ellipta is not a steroid. It is an anticholinergic bronchodilator (LAMA) that focuses specifically on relaxing airway muscles.

Can I use this for an asthma attack?

Incruse Ellipta is not a rescue inhaler and should not be used to treat sudden attacks of breathlessness or wheezing. You should always have a fast-acting reliever inhaler available for emergency symptoms.

What should I do if I miss a dose?

If you miss your daily dose, take it as soon as you remember, but do not take two doses on the same day to make up for a forgotten one.

The information provided on this page is for general informational purposes only and should not replace seeking professional advice from a doctor or pharmacist. Always consult a healthcare professional for personalised medical guidance regarding your specific condition and treatment plan.

Our content is regularly reviewed by our team of medical experts to ensure it remains up to date, accurate and aligned with the latest clinical guidelines in the UK. We strive to provide reliable information that helps you manage your health with confidence.